Join Life Sciences Pennsylvania and Teva Pharmaceutical Industries Ltd. for the National Dialogue on Schizophrenia: Pennsylvania. Staff from Mental Health Partnerships will serve on a panel with policymakers, experts, and patient advocacy groups to discuss how the life sciences ecosystem and other stakeholders are addressing this mental health condition. Click the link to register today! https://www.ticketleap.events/tickets/life-sciences-pennsylvania/national-dialogue-on-schizophrenia-pennsylvania May 2, 2025 | 9:00 a.m. (breakfast and registration) 9:30 a.m. – 11:30 a.m. (program) One Logan Square, Suite 2000 Conference Room 20A Philadelphia, PA (fb)

🛑 Medicaid is essential for Pennsylvania! 3.5 million Pennsylvanians rely on Medicaid for healthcare, with nearly 4 in 10 enrollees having a behavioral health condition. Losing coverage means losing access to therapy, medications, and crisis support. 📌 Medicaid covers 47% of Pennsylvanians with disabilities. 📌 58% of Pennsylvania’s nursing home residents rely on Medicaid. 📌 1 in 5 adults in Pennsylvania experience a mental health challenge each year—Medicaid ensures they have access to essential treatment, from therapy to crisis care. Learn how Medicaid supports PA & why we must protect it! https://interactives.commonwealthfund.org/2025/medicaid-fact-sheets/Pennsylvania.pdf and take action to preserve Medicaid: https://mhanational.salsalabs.org/March2025MedicaidAlert/index.html (fb)